Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!
Currently predicting for Mon, 13 May 2024

Trading levels for PAVM

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 2.41 13.58 %
R2 2.32 9.58 %
R1 2.27 7.11 %
Current price: 2.12
Support S1 2.10 -0.89 %
S2 2.05 -3.36 %
S3 1.96 -7.36 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 2.31 8.96 %
R2 2.24 5.66 %
R1 2.14 0.94 %
Current price 2.12
Support S1 2.04 -3.77%
S2 2.00 -5.66%
S3 1.88 -11.32%

PAVM Predictions History

3 years ago
JS predicted that PAVM for 2020-05-26 is going $2.28 (-2.56%)

3 years ago
2poJeff predicted that PAVM for 2020-05-26 is going $2.28 (-2.56%)

4 years ago
Andrew Cooke predicted that PAVM for 2020-03-09 is going

Rank:

4 years ago
JS predicted that PAVM for 2020-03-09 is going $2.61 (3.98%)

4 years ago
brian.rubendall.113111 predicted that PAVM for 2020-03-09 is going

Rank:

5 years ago
NameNotImportant predicted that PAVM for 2019-05-06 is going $1.34 (1.52%)

5 years ago
NameNotImportant predicted that PAVM for 2019-05-03 is going $1.27 (-3.79%)

5 years ago
PumpTheseNumbers predicted that PAVM for 2019-04-05 is going $1.18 (0.00%)

5 years ago
JS predicted that PAVM for 2019-04-05 is going $1.15 (-2.54%)

Click to get the best stock tips daily for free!

About PAVmed Inc

PAVmed PAVmed Inc. operates as a medical device company in the United States. The company's lead products include CarpX, a percutaneous device to treat carpal tunnel syndrome; and EsoCheck, an esophageal cell collection device for the early detection of adenocarcinoma of the esophagus and Barrett's Esophagus (BE); and EsoGuard, a bisulfite-converted next-generation sequencing DNA assay. Its product pipeline also comprises EsoCure, an esophageal ablation... PAVM Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT